IL6 and psoriasis: The acylated derivatives of luteolin inhibit imiquimod-induced psoriasis lesions in mice by down-regulating the expressions of TNF-α and IL-6 in the mouse skin tissue, increasing the contents of superoxide dismutase (SOD) and glutathione (GSH), and reducing the content of malondialdehyde (MDA).